Veracyte announces new expanded data at CHEST to support Percepta Nasal Swab Test’s ability
Veracyte, Inc. (Nasdaq: VCYT) today announced that new expanded clinical validation data reinforce the ability of the company’s noninvasive Percepta Nasal Swab test to help physicians more accurately